Dataset Information

Transport of influenza A virus neuraminidase to host cell surface and virus replication are regulated by ARHGAP21 and Cdc42

ABSTRACT: Influenza virus neuraminidase (NA), a type II transmembrane glycoprotein, is transported to the virus assembly site at the plasma membrane and is a major viral envelope component that plays a critical role in the release of progeny virions and in determination of host range restriction. Although signals/sequences in NA for translocation, sorting and raft association have been identified, little is known about the host factors that are involved in regulating the intracellular and cell surface transport of NA. In this report, we have investigated the involvement of Rho family GTPases in NA transport to the cell surface. We found that expression of constitutively active or inactive mutants of RhoA or Rac1 did not significantly affect the amount of NA that reached the cell surface. Interestingly, expression of constitutively active Cdc42 or depletion of the Cdc42-specific GAP, ARHGAP21, promoted the transport of NA to the plasma membranes. By contrast, cells expressing shRNA targrting Cdc42 or overexpressing ARHGAP21 exhibited a significant decrease in the amount of cell surface-localized NA. Furthermore, silencing of Cdc42 or ARHGAP21 had significant effects on influenza A virus replication. Together, our results reveal that ARHGAP21 and Cdc42-based signaling regulates the NA transport and thereby impacts virus replication. This microarray experiment was carried out to find out whether Cdc42 and ARHGAP21 expression levels in A549 cell were changed after WSN infection.

ORGANISM(S): Homo sapiens

PROVIDER: GSE32878 | GEO | 2012/04/04

SECONDARY ACCESSION(S): PRJNA146607

REPOSITORIES: GEO

ACCESS DATA

Similar Datasets

Project description:Influenza B virus (IBV) strains are one of the components of seasonal influenza vaccines in both trivalent and quadrivalent formulations. The vast majority of these vaccines are produced in embryonated chickens' eggs. While optimized backbones for vaccine production in eggs exist and are in use for influenza A viruses, no such backbones exist for IBVs, resulting in unpredictable production yields. To generate an optimal vaccine seed virus backbone, we have compiled a panel of 71 IBV strains from 1940 to present day, representing the known temporal and genetic variability of IBV circulating in humans. This panel contains strains from the B/Victoria/2/87-like lineage, B/Yamagata/16/88-like lineage and the ancestral lineage that preceded their split to provide a diverse set that would help to identify a suitable backbone which can be used in combination with hemagglutinin (HA) and neuraminidase (NA) glycoproteins from any IBV strain to be incorporated into the seasonal vaccine. We have characterized and ranked the growth profiles of the 71 IBV strains and the best performing strains were used for co-infection of eggs, followed by serial passaging to select for high-growth reassortant viruses. After serial passaging, we selected 10 clonal isolates based on their growth profiles assessed by hemagglutination and plaque-forming units. We then generated reverse genetics systems for the three clones that performed best in growth curves. The selected backbones were then used to generate different reassortant viruses with HA/NA combinations from high and low titer yielding wild type IBV. When the growth profiles of the recombinant reassortant viruses were tested, the low titer yielding HA/NA viruses with the selected backbones yielded higher titers similar to those from high titer yielding HA/NA combinations. The use of these IBV backbones with improved replication in eggs might increase yields for the influenza B virus components of seasonal influenza virus vaccines.

Project description:Highly pathogenic avian influenza virus (HPAIV) is a high morbidity-and mortality-associated disease that causes rapid systemic illness and death in susceptible animals. Lycorine, as the major component of Amaryllidaceae alkaloids, exhibits better protective effects against A/Chicken/Guangdong/178/2004 (GD178) than the commercial neuraminidase (NA) inhibitor oseltamivir in our prior study. Although the change of proteins of the whole cell in response to HPAIV infection have been revealed by proteomics, the mechanisms resulted in lycorine-related symptoms and the crucial factors remain to be elucidated. In this study, we carried out Multiplex tandem mass tag (TMTs) approach to analyze protein level variation of virus-infected host cells treated by lycorine using. Three groups were administrated: mock infection group (L), virus infection group (M) and virus infection and lycorine-treated after virus infection group (H). 5786 proteins were identified, among which from these three groups using TMT proteomics analysis. In M/L group, 1101 proteins were identified, of which 340 proteins were determined differentially expressed proteins during HPAIV; meanwhile, 1059 proteins were identified from lycorine-treated group, among which 259 proteins presented significant change. Here, proteins in M/L and M/H were acquired simultaneously trend, and the proteins in each fraction were analyzed. Through the enrichment analysis of Gene Ontology (GO)and KEGG pathways, we found that the up-regulated proteins in the mitogen-activated protein kinase signaling pathway and RNA transport were most enriched after HPAIV infected. There were 70 differentially abundant proteins with co-changed proteins in M/L and M/H groups were selected as the candidate proteins. Moreover, we noticed that the nuclear pore complex protein (Nup) 93 was associated with both mitogen-activated protein kinase signaling pathway and RNA transport. In addition, the Western blot experiments confirmed that the expression of Nup93 was significantly down-regulated in lycorine treatment but induced after viral infection. Conclusion: Thus, the research may provide new insight into lycorine’s underlying anti-influenza mechanisms and potential therapeutic targets for influenza virus

Dataset Information

Transport of influenza A virus neuraminidase to host cell surface and virus replication are regulated by ARHGAP21 and Cdc42

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure